(image) Substance Abuse and Mental Health Services Administration Skip To Content
(image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration
(image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration
Quick Search
Categories
Topics
Financing Center of Excellence

Persisting Decline in Depression Treatment After FDA Warnings

Posted on August 13, 2009 19:24

Categories: | | |

Topics: Children & Adolescents | Mental Health | Prescription Drugs | Regulation | Treatment

This study of depression treatment in the wake of FDA warnings regarding suicide in children taking antidepressants found that the frequency of depression diagnoses decreased and continues to decrease.  Substitute care did not compensate in non-adult groups and the authors conclude that the spillover effects of the FDA warnings were non-transitory, substantial, and diffuse in a large population.   

Libby, A. M., H. D. Orton, et al. (2009). Persisting decline in depression treatment after FDA warnings. Archives of General Psychiatry, 66(6): 633-9. http://archpsyc.ama-assn.org/cgi/content/short/66/6/633exit disclaimer small icon

Authors: Anne M. Libby, Heather D. Orton, Robert J. Valuck


E-mail to Friend | Print | Permalink | Post RSSRSS comment feed

Weekly News Pulse
National Feature Stories
SAMHSA Resources